Is this your firm? Get featured or correct your listing →
At a glance
TPG appears in 6 funding rounds tracked by ValueAddVC since 2026, leading 1. Its most frequent sectors in these rounds are AI & Infrastructure and Health & Biotech, and its most recent tracked deal was Crusoe's $3.9B Series F round (Sep 17, 2026). It co-invests most often with Andreessen Horowitz, Forbion and MGX. ValueAddVC also tracks 1 fund managed by TPG.
Strategy
Recent changes
- Sep 17, 2026Sep 17, 2026Invested in Crusoe (Series F, $3.9B) TechCrunch
- Sep 16, 2026Sep 16, 2026Invested in Sling Therapeutics (Series C, $123M) BioSpace
- Aug 13, 2026Aug 13, 2026Invested in Databricks (Strategic growth round, $5B) Bloomberg
- Jul 7, 2026Jul 7, 2026Invested in Super.com (Series D, $65M) Fortune
- May 28, 2026May 28, 2026New fund: TPG Fund X SEC EDGAR Form D
Earlier changes (1)
- Mar 31, 2026Mar 31, 2026Invested in OpenAI ($122B) TechCrunch
Funds
1| Fund | Vintage | Size | Strategy | Source |
|---|---|---|---|---|
| TPG Fund X | 2026 | — | Other | As of May 28, 2026SEC EDGAR Form D |
Portfolio
5 totalRecent Investment Activity
6Track record: led 1 and participated in 5 of 6 tracked venture rounds · 5 in the last 12 months · led 1 Series D
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Crusoe | Series F | Participated | $3.9B | $30.9B | TechCrunch | |
| Sep 16, 2026 | Sling Therapeutics | Series C | Participated | $123M | — | Pulse story | |
| Aug 13, 2026 | Databricks | Strategic growth round | Participated | $5B | $190B | Coatue ManagementLeadunverifiedBlackstoneunverifiedMGXunverifiedT. Rowe PriceunverifiedSixth StreetunverifiedBondunverifiedPoint72unverifiedPremji InvestunverifiedTPGunverifiedAndreessen HorowitzunverifiedThrive CapitalunverifiedClearlake Capital | Bloomberg |
| Jul 7, 2026 | Super.com | Series D | Led | $65M | $1.2B | TPGLeadEDC InvestmentsPlaza Asset ManagementNBA star Steph CurryShopify president Harley Finkelstein | Pulse story |
| Mar 31, 2026 | OpenAI | funding round | Participated | $122B | $852B | TechCrunch | |
| Sling Therapeutics | Series B | Participated | $123M | — | Fierce Biotech |
Sector / Stage Activity
Co-Investors
12Similar Firms
overlapping sector, stage or regionLatest Pulse
- Sep 16, 2026Sling Banks $123M To Push Oral Thyroid Eye Disease PillSling Therapeutics closed a $123 million Series C led by Forbion to fund a Phase 3 trial of linsitinib, an oral pill positioned as a more convenient alternative to injectable treatments for thyroid eye disease.→
- Aug 31, 2026Kakao Mobility's Bet on a US ListingKakao Mobility filed confidential US IPO paperwork targeting roughly a $1 billion listing, with TPG seeking an exit -- a rare instance of a Korean tech company choosing Wall Street over its home exchange.→
- Jul 27, 2026TPG in Exclusive Talks to Buy Netrality for Up to $3BPrivate equity firm TPG is in exclusive talks to acquire Macquarie-backed Netrality Data Centers in a deal that could value the carrier-neutral data center operator at up to $3 billion.→
- Jul 7, 2026Super.com Raises $65M Series D at $1.2B ValuationSuper.com raised $65 million led by TPG at a $1.2 billion valuation, positioning its savings "super app" as an Amazon Prime-style membership for everyday Americans' spending.→
TPG FAQ
What companies has TPG invested in?
TPG's portfolio includes OpenAI, Databricks, Crusoe, Sling Therapeutics, Super.com.
Who does TPG co-invest with most?
In the rounds Value Add tracks, TPG most often invests alongside Fidelity Investments (3 shared deals), T. Rowe Price (3 shared deals), Altimeter Capital (2 shared deals), Andreessen Horowitz (2 shared deals), Coatue Management (2 shared deals).
Sources & methodologyshow
- SEC EDGAR Form Dprimary source1 fact
- Bloombergmajor outlet1 fact
- Fierce Biotechmajor outlet1 fact
- Fortunemajor outlet1 fact
- TechCrunchmajor outlet1 fact
- TechCrunchmajor outlet1 fact
- BioSpaceresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.